Fred Alger Management, LLC Novo Cure LTD Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$32.0 - $52.4 $224,000 - $366,800
-7,000 Closed
0 $0
Q2 2018

Jul 19, 2018
BUY
$19.85 - $32.0 $138,950 - $224,000
7,000 New
7,000 $219,000
Q4 2017

Feb 14, 2018
SELL
$16.3 - $21.9 $16,300 - $21,900
-1,000 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$18.05 - $21.75 $18,050 - $21,750
1,000
1,000 $20,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.88B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email